Brief: Astrazeneca Says Imfinzi + EV Approved In US In Bladder Cancer
BRIEF-Astrazeneca Says Imfinzi + EV Approved In US In Bladder Cancer Nov 16 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA PLC - IMFINZI + EV APPROVED IN US IN BLADDER CANCER
ASTRAZENECA PLC - IMFINZI + EV APPROVED IN US IN BLADDER CANCER
Source text: ID:nRSP2384Da
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)